These observations suggest that JAG1 is an important node for HSC-supporting cytokines and angiogenesis-promoting factors in the leukemia vascular niche, although the molecular pathways of aberrant cytokine expression and angiocrine factor expression controlled by JAG1 and other transcription factors that may regulate JAG1 activation remain to be determined. This evidence concerns the gene JAG1 and leukemia.